Standardized Method for Quantification of Developing Lymphedema in Patients Treated for Breast Cancer
- 3 June 2010
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 79 (5), 1436-1443
- https://doi.org/10.1016/j.ijrobp.2010.01.001
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomyBreast Cancer Research and Treatment, 2010
- The Psycho-Social Impact of LymphedemaLymphatic Research and Biology, 2009
- Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutationCancer, 2009
- Familial Breast CancerAmerican Journal of Clinical Oncology, 2009
- Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation CarriersJNCI Journal of the National Cancer Institute, 2009
- International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriersInternational Journal of Cancer, 2008
- Characterization ofBRCA1andBRCA2Mutations in a Large United States SampleJournal of Clinical Oncology, 2006
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesAmerican Journal of Human Genetics, 2003
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997